Silymarin

Care Group Health Care System
Pharmacology entry for Silybum marianum

http://home.caregroup.org

Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H.
Cisplatin nephrotoxicity and protection by silibinin.

http://www.ncbi.nlm.nih.gov/Abstract

Scambia G, De Vincenzo R, Ranelletti FO, Panici PB, Ferrandina G, D'Agostino G, Fattorossi A, Bombardelli E, Mancuso S.
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin.

http://www.ncbi.nlm.nih.gov/Abstract

Invernizzi R, Bernuzzi S, Ciani D, Ascari E.
Silymarine during maintenance therapy of acute promyelocytic leukemia.

http://www.ncbi.nlm.nih.gov/Abstract

Bokemeyer C, Fels LM, Dunn T, Voigt W, Gaedeke J, Schmoll HJ, Stolte H, Lentzen H.
Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.

http://www.ncbi.nlm.nih.gov/Abstract

INTERPHARMA PRAHA, a.s., Komoranska 955, 143 10 Praha 12, Czech Republic

Business Development: 00420-241 773 242

Secretariat: 00420-241 773 242, Fax: 00420-241 773 235

 

Email: